CURCUMIN / INGREDIENT RESEARCH

Tumour invasion, spread and blood-vessel formation

Potential benefit studied: Changes in pathways involved in invasion, metastasis and angiogenesis

Supporting research

Laboratory and animal research · Reviewed 9 September 2026

This is cancer research, not a product treatment claim. These studies do not establish that Longevity or Mobility prevents, treats or cures cancer.

WHAT THE RESEARCH FOUND

Laboratory and animal research found that curcumin reduced tumour growth and changed pathways involved in invasion, metastasis and blood-vessel formation.

WHO, WHAT & HOW LONG

A 2013 pancreatic-cancer experiment used human cancer cells implanted into mice and a diet containing 0.6% curcumin for six weeks. Investigators reported smaller tumours and changes in NF-kappaB-related markers, including VEGF and MMP-9.

WHAT THIS MEANS FOR ROB’S CHOICE

The experimental diet and implanted mouse tumours do not demonstrate that Longevity or Mobility limits cancer spread. These are research findings, not a product recommendation or a reason to change oncology treatment.

The doses above describe research, not personal dosing instructions. Ingredient studies do not diagnose symptoms or establish medical suitability. Discuss medicines, existing conditions and treatment decisions with an appropriate healthcare professional.